You are here

Article Text

Article menu
Download PDFPDF
Original research
Cannabinoid home storage practices among a national Qualtrics panel of adult users of cannabinoid products in the USA
  1. Kathleen Louise Egan1,
  2. Melissa J Cox2
  1. 1 Department of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
  2. 2 Department of Health Behavior, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
  1. Correspondence to Dr Kathleen Louise Egan, Department of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, USA; klegan{at}wakehealth.edu

Abstract

Introduction The presence of cannabinoid products in the home may increase the likelihood of unintended adverse consequences for children and adolescents. Secure storage of these products is one prevention method to decrease the risk of diversion and use of cannabinoid products among youth. We sought to examine cannabis, delta-8 tetrahydrocannabinol (THC), and cannabidiol (CBD) storage practices among a sample of adults 18–64 years old residing in the USA.

Methods In December 2021, we conducted an online cross-sectional survey of 1042 current (past 30 day) users of cannabinoid products (88.3% cannabis, 49.0% delta-8 THC, and 67.2% CBD). Participants were asked about where they typically keep products in their home (ie, in a locked container, unlocked container, or out in the open). We conducted multinomial regression analyses to examine the relationship between sociodemographic characteristics and cannabinoid use behaviours with home storage practices.

Results For all products, participants more frequently reported locking, followed by storing the product in an unlocked but not visible location. Storing the product in an unlocked and visible location was endorsed the least across all three products. Participants reported more frequent endorsement of locking cannabis products as compared with delta-8-THC and CBD. Storage practices varied by biological sex, sexual orientation, ethnicity, educational attainment, having a child who lives in the home, frequency of use, possession of a medical cannabis card and exposure to advertising.

Conclusions Increasing the prevalence of secure storage practices of cannabinoid products may facilitate prevention of unanticipated consequences associated with diversion of these products.

  • behavior change
  • public health
  • poisoning
  • cross sectional study
  • drugs

Data availability statement

Data are available upon reasonable request.

https://doi.org/10.1136/ip-2023-044968

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Data availability statement

    Data are available upon reasonable request.

    View Full Text

    Footnotes

    • X @kathleenlegan

    • Contributors KLE: conceptualisation (lead), methodology (equal), formal analysis (lead), writing – original draft (lead), writing – review and editing (equal). MJC: conceptualisation; methodology (equal), writing – review and editing (equal).

    • Funding Research reported in this publication was supported by East Carolina Universiy.

    • Disclaimer The content is solely the responsibility of the authors and does not necessarily represent the official views of the East Carolina University.

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.